Despite clear evidence that many sexually transmitted disease (STD) agents can infect the cervix acutely and/or chronically, and despite the many studies linking cervical neoplasia to several individual STD agents, a critical flaw in all previous studies in failure to control for sexual behavior or to simultaneously assess the relationship of cervical intraepithelial neoplasia (CIN) to each of the agents which have been implicated in this condition. Such analyses have been found to be essential in relating sTD agents to other syndromes linked with sexual activity. We propose a set of interdisciplinary and complementary approaches to study the relationship of cervicovaginal STD pathogens to various forms of cervical dysplasia, and to less severe but common forms of cervical atypia. The proposal includes qualitative and quantitative cytopathology, together with clinical, epidemiologic, microbiologic, biochemical, genetic, and serologic studies in two populations of patients: 1) women with a high prevalence of STD who are seen in an STD clinic, and 2) women with cervical atypia or CIN and controls seen in a university hospital-based population Having thus comprehensively characterized and stratified those with or without cervical atypia on the basis of type of atypia and type of associated STD, women from the STD clinic will then be followed longitudinally to compare the natural history of various categories of atypia and STD. Proposed new techniques, many developed by the investigators, to be used for classification of atypias and detecting STD pathogens, include: 1) monoclonal antibody and improved DNA probes for the detection of STD agents in cytologic smears and in biopsies; 2) monoclonal antibodies for identification of subcellular units to classify neoplastic lesions according to cell of origin; and 3) flow cytometry and densitometry for the measurement of cellular DNA content to identify lesions with malignant potential. State-of-the-art techniques for clinical evaluation of the cervix and vagina, for serodiagnosis, and for identification and quantitation of bacterial and viral pathogens will also be employed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034493-03
Application #
3172226
Study Section
Epidemiology and Disease Control Subcommittee 3 (EDC)
Project Start
1983-12-01
Project End
1987-03-31
Budget Start
1985-12-01
Budget End
1987-03-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Xi, Long Fu; Jiang, Mingjun; Shen, Zhenping et al. (2011) Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One 6:e23897
Balasubramanian, Akhila; Kulasingam, Shalini L; Baer, Atar et al. (2010) Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis 14:185-95
Balasubramanian, Akhila; Hughes, James; Mao, Constance et al. (2009) Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer. Cancer Epidemiol Biomarkers Prev 18:3008-17
Harris, Tiffany G; Miller, Leslie; Kulasingam, Shalini L et al. (2009) Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Am J Obstet Gynecol 200:489.e1-8
Feng, Qinghua; Cherne, Stephen; Winer, Rachel L et al. (2009) Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 47:547-53
Jiang, Mingjun; Baseman, Janet G; Koutsky, Laura A et al. (2009) Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol 47:521-6
Mao, Constance; Balasubramanian, Akhila; Yu, Mujun et al. (2007) Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study. Int J Cancer 120:2435-8
Mao, Constance; Balasubramanian, Akhila; Koutsky, Laura A (2005) Should liquid-based cytology be repeated at the time of colposcopy? J Low Genit Tract Dis 9:82-8
Harris, Tiffany G; Kulasingam, Shalini L; Kiviat, Nancy B et al. (2004) Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 159:834-42
Agoff, S Nicholas; Lin, Patricia; Morihara, Janice et al. (2003) p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16:665-73

Showing the most recent 10 out of 36 publications